Precipio, Inc. (NASDAQ:PRPO) Short Interest Update

Precipio, Inc. (NASDAQ:PRPO) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 9,000 shares, an increase of 87.5% from the October 15th total of 4,800 shares. Approximately 0.7% of the shares of the stock are short sold. Based on an average daily volume of 9,600 shares, the short-interest ratio is presently 0.9 days.

Precipio Price Performance

PRPO stock traded up $0.21 during trading on Wednesday, hitting $6.35. 1,285 shares of the company’s stock traded hands, compared to its average volume of 7,369. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The business has a fifty day simple moving average of $6.47 and a 200 day simple moving average of $5.89. Precipio has a 52 week low of $4.31 and a 52 week high of $8.49.

Precipio (NASDAQ:PRPO) last announced its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter. Precipio had a negative net margin of 17.23% and a negative return on equity of 34.01%. The company had revenue of $4.44 million during the quarter.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.